Providing innovative solutions for over 30 years
We provide our customers with innovative bioanalytical solutions for protein and cell biology in life science research, pharmaceutical and biotherapeutic development.
With over 140,000 placements in laboratories around the world, our instruments have contributed to remarkable scientific research described in over 150,000 peer reviewed publications. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. We are over 1,100 associates strong with rich domain knowledge to support scientific breakthroughs. We are headquartered in Silicon Valley, the center of technology and innovation, with offices around the globe.
Innovations with Ed Begley, Jr. featuring Molecular Devices
Innovations TV tours our corporate offices and laboratories in San Jose, California to demonstrate how new technologies enable great insights. Greg Milosevich, President of Molecular Devices provides an overview of our sophisticated portfolio and its impact on the development of novel therapeutics. Fabian Zanella Ph.D., Director of R&D for StemoniX Inc., a leading provider of ready-to-use preclinical plates of biologically-relevant human micro-organs, speaks to the latest advancements in stem cell research. Zanella also explains the importance of sophisticated instrumentation in the fast-paced environment of cell biology.
First microplate reader in space
Molecular Devices SpectraMax M5e reader, chosen for its durability, became the first microplate reader in space in May 2011. NanoRacks, a leading provider of commercial pathway solutions aboard the International Space Station, added the reader to their line of commercial research hardware, providing researchers the ability to conduct microplate reader experiments in microgravity for the first time.
They reconfigured the reader to operate comfortably in the zero-gravity environment of the space station. Upgrades included temperature control and the ability to configure every aspect of the researcher’s experiment from an Earth-based workstation using SoftMax® Pro, the leading data acquisition and analysis software. NanoRacks re-launched the reconfigured SpectraMax M5e reader back to the International Space Station on the SpaceX Commercial Resupply Mission-9 on July 18, 2016.
Our Quality Management System is compliant to the requirements of ISO9001 International Standard that enhances our ability to design, develop, manufacture, deliver, maintain and support our products according to the highest quality standards continually and consistently.
We are also ISO/IEC 17025 accredited for validation plate calibration and re-calibration processes for microplate readers. All calibration procedures performed at Molecular Devices comply with the ISO/IEC 17025 criteria.
At Molecular Devices, LLC, our products are RoHS compliant and meet material restriction requirements adopted under European RoHS, Directive 2011/65/EU. This legislation restricts the use of Lead, Cadmium, Mercury, Hexavalent Chromium, Poly-Brominated Bi-Phenyls (PBB), and Poly-Brominated Di-Phenyl Ethers (PBDE) in products that are put on the market in EU member countries.
China RoHS Certified
The European Union’s REACH regulation (Regulation No 1907/2006 on the Registration, Evaluation, Authorization and Restriction of Chemicals) places obligations as manufacturers, importers and downstream users of chemical substances and preparations. It also places obligations on importers of products. Article 33 of REACH requires suppliers to inform recipients if any article contains more than 0.1% (by weight per article) of any substance(s) on the candidate list of Substances of Very High Concern (SVHC). Based on the European Court of Justice (ECJ) ruling on September 10, 2015, each component of a complex product is considered an article. The European Chemical Agency (ECHA) periodically publishes SVHC candidate list on their website at URL: http://echa.europa.eu/candidate-list-table. A list of SVHCs present above 0.1% by weight in any article of Molecular Device’s products is available by emailing firstname.lastname@example.org.
Under the Waste Electrical and Electronic Equipment (WEEE) Directive and implementing regulations, when customers buy new electrical and electronic equipment from Molecular Devices they are entitled to:
- send old equipment for recycling on a one-for-one, like-for-like basis (this varies depending on the country)
- send the new equipment back for recycling when this ultimately becomes waste
Instructions to both customers and recyclers/treatment facilities wishing to obtain disassembly information are found on the WEEE Information page.
Proposition 65 requires businesses to provide warnings to Californians about significant exposures to chemicals that cause cancer, birth defects or other reproductive harm. Proposition 65 also prohibits California businesses from knowingly discharging significant amounts of listed chemicals into sources of drinking water. Molecular Devices products are labeled and meet Proposition 65 requirements. For more information, go to www.P65Warnings.ca.gov.
At Molecular Devices, we provide one of the widest ranges of bioanalytical systems for life science and drug discovery research available from a single supplier. Our systems are built on proprietary technology platforms that deliver high performance, flexibility, and reliability. Some of our key patented technologies can be viewed here. For more information about any of these technologies, please contact us directly.
Integrity & Compliance
Please visit www.danaher.com/how-we-work/integrity-and- compliance for a copy of our Standards of Conduct, to make a report on the Danaher Integrity and Compliance Helpline, and for details regarding Danaher and its subsidiaries’ compliance with the California Transparency in Supply Chains Act of 2010.
Modern Slavery Act 2015 Compliance
Please visit http://investors.danaher.com/corporate-governance (under Policies & Reports) for details regarding Danaher and its subsidiaries’ compliance with the Modern Slavery Act 2015.
Molecular Devices introduces enterprise-level SoftMax Pro 7.1 GxP SoftwareRead
Molecular Devices announces brand identity for its newly-formed biologics business unitRead
Upcoming Episode of Innovations TV Highlights the Molecular Devices High Content Imaging PlatformRead
Are you passionate about designing, building, and supporting industry-leading solutions that help improve the quality of human life every single day? Join us and work with best-in-class teams to build innovative tools that advance our customers’ scientific discoveries.
Join our team